Details

Last Funding Type

Series B

Industries

Biotechnology,Pharmaceutical

Founded date

Apr 1, 2013

Number Of Employee

1 - 10

Operating Status

Active

Deyi Sunshine Biotechnology (Beijing) Co., Ltd. was established in April 2013 in Zhongguancun Biomedical Park, Haidian District, Beijing. In March 2014, it established a subsidiary Deyang Biotechnology in Gu'an Emerging Industry Demonstration Zone, Langfang City, Hebei Province. (Gu'an) limited liability company. Deyi Sunshine is a biotechnology company focused on developing a new class of drugs. The company has a world-leading innovative biopharmaceutical research and development platform. Based on the analysis of the industry and relying on the unique core technology-Sunshine Protein Optimization Platform, the company has successfully developed Pegelan (a kind of innovation for treating chronic norovirus infection in patients with immune deficiency). Orphan drug), Sporphene (an innovative orphan drug for minimally invasive repair of articular cartilage injury), Perox (an innovative orphan drug for the treatment of stubborn gout with visible crystals) and Defenfen (for the treatment of lupus erythematosus) A class of innovative drugs for renal failure and uremia) and many other world-leading research results. The research varieties all have independent intellectual property rights of the active ingredients of the drug. It is expected that the future listing will not only bring good news to the patients with rare diseases in the world, but also hope to expand into other indications and become a major innovative product. All the staff of the company adhere to the tenet of “Deze human beings, benefit the country and the people, and the healthy people”. We have the entrepreneurial spirit of “independent innovation and courage to open up” and make unremitting efforts to build China's first-class bio-pharmaceutical company!